Use of sodium-glucose co-transporter-2 inhibitors in patients with type 2 diabetes mellitus and multiple cardiovascular risk factors: An Asian perspective and expert recommendations

Topics: 

Citation
Deerochanawong C, et al.Diabetes Obes Metab 2019;21(11):2354-2367.